Fig. 2.
Overall survival.
Comparison of overall survival between patients eligible to receive CD6 T-cell–depleted BMT and CD4+ DLI and a cohort of patients treated previously with CD6 BMT alone.
Overall survival.
Comparison of overall survival between patients eligible to receive CD6 T-cell–depleted BMT and CD4+ DLI and a cohort of patients treated previously with CD6 BMT alone.
